Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Resistance Assay HCVGEN3NS5A

Synonyms

Allscripts (AEHR) Order Name

Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Resistance Assay

Sunrise Clinical Manager (SCM) Order Name

Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Re

EPIC Order Name

Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Resistance Assay

Clinical Info

Use
Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. 
Assay should be used for patients with documented HCV genotype 3.

Specimen Type

Blood

Specimen Volume

2.0 mL plasma from Lav top tube (1.0 mL Minimum volume)

Container

Lavender Top Tube

Collection Instructions

Collection Instructions
Collect specimen in lavender-top (EDTA) tubes. Do not use green-top (heparin) tubes. 
Centrifuge specimen within six hours of collection, remove plasma, transfer specimen to 
polypropylene screw-capped tubes, and freeze. Ship frozen.

Transport Instructions

Frozen

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing (NGS)

Days Performed

TAT: 11-15 Days

Performing Laboratories

  • NWH CL Send Outs-Labcorp

CPT

87900,87902

PDM

255666

Result Interpretation

Special Instructions
Please confirm the patient's HCV genotype 3 prior to submitting sample for testing.

Limitations
This procedure may not be successful when the HCV viral load is <500 IU/mL. 
This assay requires an HCV genotype of 3.

Forms


edit